Healthcare
Tilray Brands, Inc.(TLRY)
Live Price
Offline$4.73
-0.42% today
1Y Change
+38.33%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $740.00M
- Revenue Growth
- +4.8%
- EPS Growth
- -651.1%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tilray Brands, Inc. (TLRY) is a Healthcare stock with a market cap of $740.00M and listed on NASDAQ. The stock last traded around $4.73 and up 38.3% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +4.8%, EPS growth of -651.1%, a dividend yield of 0.0%. What stands out right now is revenue +4.8%, EPS -651.1%, free cash flow -113.5% with operating margin -172.3% and ROIC -100.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TLRY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+4.8% vs +7.6% peer median
Operating Margin
Below sector median
-172.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Apr 1, 2026 with an EPS surprise of -71.4% and a revenue surprise of +2.7%.
The operating picture looks softer than before
Revenue is at +4.8% and EPS is at -651.1%, with operating margin around -172.3%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 27, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.6% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 1, 2026 | -71.4% | +6.7% | +9.4% | +1.6% |
2026 Jan 8, 2026 | -192.9% | +0.5% | +6.4% | -17.0% |
2025 Oct 9, 2025 | +98.4% | -18.1% | -26.7% | -42.4% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TLRY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TLRY Max Drawdown
-76.48%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TLRY and SPY.
Company Overview
Tilray Brands, Inc.
NASDAQ Global Select
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
- Leadership
- Irwin David Simon
- IPO Date
- Jul 19, 2018
- Employees
- 2.6k
- Street Address
- 265 Talbot Street West
- Mailing
- Leamington, ON, N8H 5L4
- Region
- Leamington, ON, CA
- Reporting Currency
- USD
- Investor Line
- 12064329325
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.6
- Price/Book
- 0.4
Growth
- Revenue
- +4.8%
- EPS
- -651.1%
- Free Cash Flow
- -113.5%
Profitability
- Gross Margin
- 27.7%
- Operating Margin
- -172.3%
- Net Margin
- -156.2%
- ROE
- -92.8%
- ROIC
- -100.9%
Balance Sheet
- Debt/Equity
- 0.20
- Current Ratio
- 2.79
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.